When a breast ultrasound finding is assigned BI-RADS category 4, the report communicates suspicion that warrants tissue diagnosis, not a cancer diagnosis. In the ACR BI-RADS ultrasound lexicon, category 4 sits between probably benign (category 3) and highly suggestive of malignancy (category 5). Likelihood of malignancy spans greater than 2% up to less than 95%, which is why 4A, 4B, and 4C subcategories matter for counseling and for practice audit. This walkthrough covers assigning category 4 from ultrasound descriptors, how it differs from adjacent categories, and common reporting pitfalls.
What BI-RADS Category 4 Means on Breast Ultrasound
BI-RADS 4 meaning at the management level is simple: a suspicious abnormality is present and biopsy is recommended. It is not histology, not a cancer stage, and not a treatment plan. Many category 4 lesions prove benign after sampling, especially 4A. Assign the assessment to the most suspicious finding after correlation with mammography, clinical history, and other available breast imaging.
Use category 4 when suspicious ultrasound features are present but the combination does not reach the very high likelihood required for category 5. Category 0 is for incomplete evaluation. Do not use category 4 as a placeholder when more imaging is still needed to characterize the finding.
BI-RADS 4A, 4B, and 4C Subcategories
The ACR subdivides category 4 because one bucket from just over 2% to just under 95% is too broad. Subcategory assignment is a judgment based on the number and strength of suspicious features, not a numeric score.
- 4A, low suspicion: greater than 2% and up to 10% likelihood of malignancy. Limited suspicious features. Examples include an otherwise oval, parallel solid mass with a focally indistinct margin, a complicated cyst that cannot be called probably benign, or an intraductal mass without frankly malignant features.
- 4B, moderate suspicion: greater than 10% and up to 50%. Mixed or intermediate features, such as an irregular hypoechoic mass with microlobulated margins or a complex cystic and solid mass without spiculation.
- 4C, high suspicion: greater than 50% and less than 95%. Nearly classic malignant morphology that still falls short of category 5, for example an irregular, nonparallel mass with angular margins but without a highly spiculated appearance.
If you cannot support a subcategory, still assign category 4 and recommend tissue diagnosis. Omitting 4A, 4B, or 4C is permitted, but it weakens counseling and audit of positive predictive value.
Ultrasound Lexicon Features That Support a Suspicious Assessment
Describe the finding with ACR ultrasound descriptors first, then assign the assessment. Features that commonly support BI-RADS category 4 include:
- Shape: irregular rather than oval or round.
- Orientation: not parallel (taller than wide).
- Margin: not circumscribed (indistinct, angular, microlobulated, or spiculated). Spiculation pushes likelihood toward 4C or 5.
- Echo pattern and posterior features: marked hypoechogenicity with shadowing is more concerning than uniform isoechogenicity with enhancement, though neither finding alone assigns the category.
- Calcifications: in a mass or intraductal, particularly punctate echogenic foci that shadow.
- Associated features: architectural distortion, duct changes, skin thickening or retraction, and increased vascularity in a suspicious mass.
- Special cases: complex cystic and solid masses, and many intraductal masses, are typically category 4 rather than 3.
No single descriptor automatically equals category 4. A circumscribed, oval, parallel solid mass without suspicious features is usually category 3, or category 2 if it is a simple cyst or other characteristically benign finding. One concerning margin or orientation feature often moves the assessment into 4A or higher.
How Category 4 Differs From Other BI-RADS Categories
- Category 2, benign: simple cysts, typical intramammary nodes, stable postsurgical change, and other findings with essentially no likelihood of malignancy. No short-interval follow-up and no biopsy for that finding.
- Category 3, probably benign: 2% or lower likelihood of malignancy. Classic ultrasound example: a solitary, oval, parallel, circumscribed solid mass. Management is typically short-interval follow-up, not immediate biopsy, unless sampling is preferred clinically.
- Category 4: greater than 2% to less than 95%. Tissue diagnosis is recommended.
- Category 5: 95% or higher. Biopsy is still required before treatment. Do not skip sampling because the imaging looks classic.
If you would not be comfortable following the lesion, it is not category 3. If the constellation of features is classic for malignancy, use 5 so that a benign biopsy prompts discordant review rather than casual acceptance.
Management After a Category 4 Ultrasound Assessment
The usual next step is image-guided percutaneous biopsy. Ultrasound-guided core needle biopsy is preferred when the target is visible on ultrasound. Fine-needle aspiration has a limited role for solid masses when core biopsy is available. Clip placement and post-biopsy mammography, when appropriate, confirm sampling of the intended lesion.
Category 4 is not a cancer stage and not a treatment plan. Any surgery or systemic therapy depends on histology and staging after a malignant result. A benign, concordant result typically returns the patient to routine screening or to follow-up that matches the histology. Discordant pathology, such as a benign result for a 4C or 5 mass, should trigger multidisciplinary review and often repeat sampling or excision.
Reporting Pearls and Pitfalls
- Lead the impression with the assessment and a clear statement that tissue diagnosis is recommended.
- Use 4A, 4B, or 4C whenever you can, and add one clause explaining why.
- Correlate with mammography when it was performed. A sonographic correlate to a mammographic mass is one finding, not two conflicting categories.
- Do not upgrade every complicated cyst. Many isolated, classic complicated cysts are category 3. Reserve 4A for lesions that are not a confident complicated cyst.
- Do not use category 4 for technical limits or incomplete mammographic workup. That is category 0.
- Do not equate category 4 with cancer in the report. Patients often read these reports.
- Document size, clock-face location, distance from the nipple, and the most suspicious portion of a heterogeneous mass so biopsy is targeted correctly.
The same lexicon-based discipline applies in other organs. ACR TI-RADS scores thyroid nodules with a points system rather than a gestalt category. If you also interpret neck ultrasound, see TI-RADS for managing thyroid nodules on ultrasound and the TI-RADS case series.
Consistent ACR descriptors, honest 4A/4B/4C assignment, and careful imaging-pathology correlation keep BI-RADS category 4 useful at the scanner and in the reading room. IAME offers accredited ultrasound CME courses in breast imaging for clinicians who want structured case review of scanning technique, lexicon, and reporting.
Frequently Asked Questions
Does BI-RADS 4 mean cancer?
No. Category 4 means the finding is suspicious and biopsy is recommended. Likelihood of malignancy ranges from just above 2% to just below 95%, depending on subcategory. A substantial share of category 4 lesions, particularly 4A, are benign after sampling.
Is biopsy recommended for a BI-RADS category 4 suspicious abnormality?
Yes. The ACR management recommendation for category 4 is tissue diagnosis. Ultrasound-guided core needle biopsy is typically used when the lesion is seen on ultrasound. Final decisions still depend on imaging-pathology concordance and clinical judgment.
What percentage of BI-RADS 4 findings are benign?
There is no single percentage, because category 4 spans a very wide risk range. Subcategory 4A (greater than 2% and up to 10% malignant) is often benign, 4B is mixed, and 4C is more often malignant. Positive predictive values also vary by practice and by how consistently subcategories are applied.
Is BI-RADS 4 treatable, and what stage of cancer is it?
BI-RADS 4 is not a cancer stage and does not by itself mean that treatment is needed. Staging and therapy apply only after a tissue diagnosis of malignancy. Many category 4 findings are not cancer. Those that are malignant are treated according to histology and stage, not according to the imaging category.
Is BI-RADS 4 always cancer?
No. BI-RADS 4 is never a diagnosis of cancer. It is an imaging assessment that the finding is suspicious enough to sample. Cancer is established only by pathology, and a benign concordant biopsy is a common outcome, especially in 4A.
